Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Surbhi Sharma & Shweta Dang. (2023) Polysorbate 80 surface modified PLGA nanoparticles: an in-vitro evaluation of cellular uptake and cytotoxicity on neuro-2a cells. Journal of Microencapsulation 0:0, pages 1-15.
Read now
Read now
Ziqi Gu, Haishu Chen, Han Zhao, Wanting Yang, Yilan Song, Xiang Li, Yang Wang, Dan Du, Haikang Liao, Wenhao Pan, Xi Li, Yajuan Gao, Hongbin Han & Zhiqian Tong. (2022) New insight into brain disease therapy: nanomedicines-crossing blood–brain barrier and extracellular space for drug delivery. Expert Opinion on Drug Delivery 19:12, pages 1618-1635.
Read now
Read now
Badriyah Shadid Alotaibi, Manal Buabeid, Nihal Abdalla Ibrahim, Zelal Jaber Kharaba, Munazza Ijaz, Sobia Noreen & Ghulam Murtaza. (2021) Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature. International Journal of Nanomedicine 16, pages 7517-7533.
Read now
Read now
Atinderpal Kaur, Kuldeep Nigam, Sukriti Srivastava, Amit Tyagi & Shweta Dang. (2020) Memantine nanoemulsion: a new approach to treat Alzheimer’s disease. Journal of Microencapsulation 37:5, pages 355-365.
Read now
Read now
Xiao Hu, Feifei Yang, Yonghong Liao, Lin Li & Lan Zhang. (2017) Cholesterol–PEG comodified poly (N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations. Drug Delivery 24:1, pages 121-132.
Read now
Read now
Wenjun Chen, Miao Guo & Shuli Wang. (2016) Anti prostate cancer using PEGylated bombesin containing, cabazitaxel loading nano-sized drug delivery system. Drug Development and Industrial Pharmacy 42:12, pages 1968-1976.
Read now
Read now
Gülsel Yurtdaş Kırımlıoğlu, Yusuf Menceloğlu, Kevser Erol & Yasemin Yazan. (2016) In vitro/in vivo evaluation of gamma-aminobutyric acid-loadedN,N-dimethylacrylamide-based pegylated polymeric nanoparticles for brain delivery to treat epilepsy. Journal of Microencapsulation 33:7, pages 625-635.
Read now
Read now
Yahya E. Choonara, Pradeep Kumar, Girish Modi & Viness Pillay. (2016) Improving drug delivery technology for treating neurodegenerative diseases. Expert Opinion on Drug Delivery 13:7, pages 1029-1043.
Read now
Read now
Ibrahim Elsayed & Mohamed Hassan Hany AbouGhaly. (2016) Inhalable nanocomposite microparticles: preparation, characterization and factors affecting formulation. Expert Opinion on Drug Delivery 13:2, pages 207-222.
Read now
Read now
Shujuan Li, Xiaoyu Wang, Yingying Wang, Qianqian Zhao, Lina Zhang, Xinggang Yang, Dandan Liu & Weisan Pan. (2015) A novel osmotic pump-based controlled delivery system consisting of pH-modulated solid dispersion for poorly soluble drug flurbiprofen: in vitro and in vivo evaluation. Drug Development and Industrial Pharmacy 41:12, pages 2089-2099.
Read now
Read now
Abdul Wadood Khan, Sabna Kotta, Shahid Husain Ansari, Rakesh Kumar Sharma & Javed Ali. (2015) Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier. Drug Development and Industrial Pharmacy 41:5, pages 772-779.
Read now
Read now
Articles from other publishers (70)
Varsha Tiwari, Abhishek Tiwari, Ajay Sharma, Manish Kumar, Deepak Kaushik & Suresh Sagadevan. (2023) An optimistic approach to nanotechnology in Alzheimer's disease management: An overview. Journal of Drug Delivery Science and Technology 86, pages 104722.
Crossref
Crossref
Thuy Trang Nguyen, Phuong-Trang Nguyen-Thi, Thi Hong Anh Nguyen, Thanh-Tam Ho, Nguyen-Minh-An Tran, Toi Van Vo & Giau Van Vo. (2023) Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders. Molecular Diagnosis & Therapy 27:4, pages 457-473.
Crossref
Crossref
Yiting Luo, Yunli Xia, Haonan Zhang, Yunzhu Lin, Lili He, Tao Gong, Zhirong Zhang & Li Deng. (2023) Human Serum Albumin-enriched Clopidogrel Bisulfate Nanoparticle Alleviates Cerebral Ischemia–Reperfusion Injury in Rats. Pharmaceutical Research 40:7, pages 1821-1833.
Crossref
Crossref
Zhiren Wang, Karina Marie Gonzalez, Leyla Estrella Cordova & Jianqin Lu. (2023) Nanotechnology‐empowered therapeutics targeting neurodegenerative diseases. WIREs Nanomedicine and Nanobiotechnology.
Crossref
Crossref
Sara Hernando, Edorta Santos‐Vizcaíno, Manoli Igartua & Rosa Maria Hernandez. (2023) Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease. WIREs Nanomedicine and Nanobiotechnology.
Crossref
Crossref
Thirunavukkarsu Palaniyandi, Kanagavalli B, Pranav Prabhakaran, Sandhiya Viswanathan, Mugip Rahaman Abdul Wahab, Sudhakar Natarajan, Senthil Kumar Kaliya Moorthy & Saravanan Kumarasamy. (2023) Nanosensors for the diagnosis and therapy of neurodegenerative disorders and inflammatory bowel disease. Acta Histochemica 125:2, pages 151997.
Crossref
Crossref
Fahad Saad Alhodieb, Mohammad Akhlaquer Rahman, Muhammad Abul Barkat, Abdulkareem A Alanezi, Harshita Abul Barkat, Hazrina Ab Hadi, Ranjit K Harwansh & Vineet Mittal. (2023) Nanomedicine-driven therapeutic interventions of autophagy and stem cells in the management of Alzheimer's disease. Nanomedicine 18:2, pages 145-168.
Crossref
Crossref
Ljiljana Djekic. 2023. Nasal Drug Delivery. Nasal Drug Delivery
189
234
.
Li Li, Rendong He, Haili Yan, Zhengwei Leng, Shuang Zhu & Zhanjun Gu. (2022) Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis. Nano Today 47, pages 101654.
Crossref
Crossref
Kshama A. Doshi. 2022. Targeted Drug Delivery. Targeted Drug Delivery
1
19
.
Atinderpal Kaur, Kuldeep Nigam, Amit Tyagi & Shweta Dang. (2022) A Preliminary Pharmacodynamic Study for the Management of Alzheimer’s Disease Using Memantine-Loaded PLGA Nanoparticles. AAPS PharmSciTech 23:8.
Crossref
Crossref
Margarita E. Neganova, Yulia R. Aleksandrova, Olga A. Sukocheva & Sergey G. Klochkov. (2022) Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Seminars in Cancer Biology 86, pages 805-833.
Crossref
Crossref
Débora Nunes, Joana A. Loureiro & Maria Carmo Pereira. (2022) Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer’s Drugs. Pharmaceutics 14:11, pages 2296.
Crossref
Crossref
Pratikshya Sa, Priya Singh, Fahima Dilnawaz & Sanjeeb Kumar Sahoo. (2022) Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment
of CNS Disorders: Challenges and Possibilities. Current Pharmaceutical Design 28:33, pages 2742-2757.
Crossref
Crossref
Livia La Barbera, Emanuele Mauri, Marcello D’Amelio & Manuele Gori. (2022) Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives. Frontiers in Neuroscience 16.
Crossref
Crossref
Miguel Pinto, Vera Silva, Sandra Barreiro, Renata Silva, Fernando Remião, Fernanda Borges & Carlos Fernandes. (2022) Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform. Ageing Research Reviews 79, pages 101658.
Crossref
Crossref
Philippe Delbreil, Jean-Michel Rabanel, Xavier Banquy & Davide Brambilla. (2022) Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings. Advanced Drug Delivery Reviews 187, pages 114397.
Crossref
Crossref
Simona Martano, Valeria De Matteis, Mariafrancesca Cascione & Rosaria Rinaldi. (2022) Inorganic Nanomaterials versus Polymer-Based Nanoparticles for Overcoming Neurodegeneration. Nanomaterials 12:14, pages 2337.
Crossref
Crossref
Kajal Tak, Prashansa Sharma, Rekha Sharma, Vivek Dave, Smita Jain & Swapnil Sharma. (2022) One-pot hydrothermal green synthesis of Polygala tenuifolia mediated graphene quantum dots for acetylcholine esterase inhibitory activity. Journal of Drug Delivery Science and Technology 73, pages 103486.
Crossref
Crossref
Smita P. Kakad, Trupti D. Gangurde, Sanjay J. Kshirsagar & Vaishali G. Mundhe. (2022) Nose to brain delivery of nanosuspensions with first line antiviral agents is alternative treatment option to Neuro-AIDS treatment. Heliyon 8:7, pages e09925.
Crossref
Crossref
Sumanta Samanta, Vadim Le Joncour, Olivia Wegrzyniak, Vignesh Kumar Rangasami, Harri Ali‐Löytty, Taehun Hong, Ram Kumar Selvaraju, Ola Aberg, Jons Hilborn, Pirjo Laakkonen, Oommen P. Varghese, Olof Eriksson, Horacio Cabral & Oommen P. Oommen. (2022) Heparin‐Derived Theranostic Nanoprobes Overcome the Blood–Brain Barrier and Target Glioma in Murine Model. Advanced Therapeutics 5:6, pages 2200001.
Crossref
Crossref
Francisco Fabián Razura-Carmona, Alejandro Perez-Larios, Sonia Guadalupe Sáyago-Ayerdi, Mayra Herrera-Martínez & Jorge Alberto Sánchez-Burgos. (2022) Biofunctionalized Nanomaterials: Alternative for Encapsulation Process Enhancement. Polysaccharides 3:2, pages 411-425.
Crossref
Crossref
Saliha Aydin, Ilke Kabaoglu, Ece Guler, Fadime Topal, Ayse Nur Hazar‐Yavuz, Ceyda Ekentok, Esra Tatar, Fatmanur Gurbuz, Oguzhan Gunduz & Muhammet Emin Cam. (2022) A Comparison Study of Fiber Diameter's Effect on Characteristic Features of Donepezil/Curcumin‐Loaded Polycaprolactone/Polylactic Acid Nanofibers. Macromolecular Materials and Engineering 307:5.
Crossref
Crossref
J. P. Jose Merlin & Xiaogang Li. (2022) Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases. Frontiers in Genetics 12.
Crossref
Crossref
Syed Nasir Abbas Bukhari. (2022) Nanotherapeutics for Alzheimer's Disease with Preclinical Evaluation and
Clinical Trials: Challenges, Promises and Limitations. Current Drug Delivery 19:1, pages 17-31.
Crossref
Crossref
Pallav Namdeo, Jinu Mathew & Ashish Garg. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases
223
242
.
Francisca Espinoza, Walther Ide, Natalia Saldivia & Diego Zelada. 2022. Polymeric Biomaterials for Healthcare Applications. Polymeric Biomaterials for Healthcare Applications
369
402
.
M. Vijay Kumar & Kartik Bhairu Khot. 2022. Functional Foods and Therapeutic Strategies for Neurodegenerative Disorders. Functional Foods and Therapeutic Strategies for Neurodegenerative Disorders
163
176
.
David Lee & Tamara Minko. (2021) Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier. Pharmaceutics 13:12, pages 2049.
Crossref
Crossref
Mohammed H. Elkomy, Rasha A. Khallaf, Mohamed O. Mahmoud, Raghda R. S. Hussein, Asmaa M. El-Kalaawy, Abdel-Razik H. Abdel-Razik & Heba M. Aboud. (2021) Intratracheally Inhalable Nifedipine-Loaded Chitosan-PLGA Nanocomposites as a Promising Nanoplatform for Lung Targeting: Snowballed Protection via Regulation of TGF-β/β-Catenin Pathway in Bleomycin-Induced Pulmonary Fibrosis. Pharmaceuticals 14:12, pages 1225.
Crossref
Crossref
Claudia Riccardi, Filomena Napolitano, Daniela Montesarchio, Simone Sampaolo & Mariarosa Anna Beatrice Melone. (2021) Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases. Pharmaceutics 13:11, pages 1897.
Crossref
Crossref
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tuong Kha Vo, Nguyen-Minh-An Tran, Minh Kim Nguyen, Toi Van Vo & Giau Van Vo. (2021) Nanotechnology-based drug delivery for central nervous system disorders. Biomedicine & Pharmacotherapy 143, pages 112117.
Crossref
Crossref
Mingoo Bae, Seung Yon Han, Eun-Sun Kim, Byung Hoon You, Young-Mi Kim, Jungsook Cho, Young-Won Chin & Young Hee Choi. (2021) Effect of Water Extract of Mangosteen Pericarp on Donepezil Pharmacokinetics in Mice. Molecules 26:17, pages 5246.
Crossref
Crossref
Ze Qiang Zhao, Bo Zhi Chen, Xiao Peng Zhang, Hui Zheng & Xin Dong Guo. (2021) An Update on the Routes for the Delivery of Donepezil. Molecular Pharmaceutics 18:7, pages 2482-2494.
Crossref
Crossref
Yilan Xu, Manna Zhao, Dongming Zhou, Tingting Zheng & Heng Zhang. (2021) The application of multifunctional nanomaterials in Alzheimer’s disease: A potential theranostics strategy. Biomedicine & Pharmacotherapy 137, pages 111360.
Crossref
Crossref
Shiv Bahadur & Kamla Pathak. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
187
207
.
Farrukh Zeeshan, Dinesh Kumar Mishra & Prashant Kesharwani. 2021. Theory and Applications of Nonparenteral Nanomedicines. Theory and Applications of Nonparenteral Nanomedicines
153
180
.
Sara Silva, António J. Almeida & Nuno Vale. (2021) Acetylcholinesterase inhibitors and nanoparticles on Alzheimer’s disease: a review. Journal of Nanoparticle Research 23:1.
Crossref
Crossref
Kristian Kempe & Joseph A. Nicolazzo. 2021. Nanomedicines for Brain Drug Delivery. Nanomedicines for Brain Drug Delivery
1
27
.
Archana S. Nayak, Srivani Chodisetti, Shivaprasad Gadag, Usha Yogendra Nayak, Srinikethan Govindan & Keyur Raval. (2020) Tailoring solulan C24 based niosomes for transdermal delivery of donepezil: In vitro characterization, evaluation of pH sensitivity, and microneedle-assisted Ex vivo permeation studies. Journal of Drug Delivery Science and Technology 60, pages 101945.
Crossref
Crossref
Atinderpal Kaur, Kuldeep Nigam, Ishita Bhatnagar, Himanshu Sukhpal, Stuti Awasthy, Shivanika Shankar, Amit Tyagi & Shweta Dang. (2020) Treatment of Alzheimer’s diseases using donepezil nanoemulsion: an intranasal approach. Drug Delivery and Translational Research 10:6, pages 1862-1875.
Crossref
Crossref
Jingwei Shao, Yifan Fang, Ruirui Zhao, Fangmin Chen, Mingyue Yang, Jiali Jiang, Zixuan Chen, Xiaotian Yuan & Lee Jia. (2020) Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid. Asian Journal of Pharmaceutical Sciences 15:6, pages 685-700.
Crossref
Crossref
Barnabas Wilson & Kannoth Mukundan Geetha. (2020) Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease. Journal of Controlled Release 325, pages 25-37.
Crossref
Crossref
Niloufar Choubdar & Sara Avizheh. (2020) Nanotechnology Based Delivery Systems of Drugs Currently Used to Treat Alzheimer’s Disease. Nanoscience & Nanotechnology-Asia 10:3, pages 228-247.
Crossref
Crossref
Gülcem Altinoglu & Terin Adali. (2020) Alzheimer’s Disease Targeted Nano-Based Drug Delivery Systems. Current Drug Targets 21:7, pages 628-646.
Crossref
Crossref
Anmol Dogra, R.S. Narang & Jasjeet K. Narang. (2020) Recent Advances in Nanotherapeutic Interventions for the Treatment of Alzheimer’s Disease. Current Pharmaceutical Design 26:19, pages 2257-2279.
Crossref
Crossref
Khaled S. Shamarekh, Heba A. Gad, Mahmoud E. Soliman & Omaima A. Sammour. (2020) Development and evaluation of protamine-coated PLGA nanoparticles for nose-to-brain delivery of tacrine: In-vitro and in-vivo assessment. Journal of Drug Delivery Science and Technology 57, pages 101724.
Crossref
Crossref
Hossein Derakhshankhah, Soraya Sajadimajd, Samira Jafari, Zhila Izadi, Sajad Sarvari, Majid Sharifi, Mojtaba Falahati, Faezeh Moakedi, Willis Collins Akeyo Muganda, Mareike Müller, Mohammad Raoufi & John F. Presley. (2020) Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy. Nanomedicine: Nanotechnology, Biology and Medicine 24, pages 102149.
Crossref
Crossref
L. Ronibala Singha, Punamjyoti Das, Nasima Ahmed, Malay K. Das, Sanjoy Das & Trinayan Deka. 2020. Nano Medicine and Nano Safety. Nano Medicine and Nano Safety
143
173
.
Akhand Pratap Singh, Arpan Biswas, Aparna Shukla & Pralay Maiti. (2019) Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal Transduction and Targeted Therapy 4:1.
Crossref
Crossref
Miguel Pinto, Carlos Fernandes, Eva Martins, Renata Silva, Sofia Benfeito, Fernando Cagide, Ricardo F. Mendes, Filipe A. Almeida Paz, Jorge Garrido, Fernando Remião & Fernanda Borges. (2019) Boosting Drug Discovery for Parkinson’s: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles. Pharmaceutics 11:7, pages 331.
Crossref
Crossref
Amanda Cano, Miren Ettcheto, Jui-Hsien Chang, Emma Barroso, Marta Espina, Britta A. Kühne, Marta Barenys, Carmen Auladell, Jaume Folch, Eliana B. Souto, Antoni Camins, Patric Turowski & Maria Luisa García. (2019) Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model. Journal of Controlled Release 301, pages 62-75.
Crossref
Crossref
Josef Jampílek, Katarína Kráľová, Petr Novák & Michal Novák. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
65
138
.
Sathika G. G. Arachchige, Ryan Rienzie & Nadeesh M. Adassooriya. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
267
287
.
Brendan M. Ottemann, Austin J. Helmink, Wenting Zhang, Insiya Mukadam, Christopher Woldstad, James R. Hilaire, Yutong Liu, JoEllyn M. McMillan, Benson J. Edagwa, R. Lee Mosley, Jered C. Garrison, Bhavesh D. Kevadiya & Howard E. Gendelman. (2018) Bioimaging predictors of rilpivirine biodistribution and antiretroviral activities. Biomaterials 185, pages 174-193.
Crossref
Crossref
Muhammad Ovais, Nashmia Zia, Irshad Ahmad, Ali Talha Khalil, Abida Raza, Muhammad Ayaz, Abdul Sadiq, Farhat Ullah & Zabta Khan Shinwari. (2018) Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer’s Disease: Present Status and Future Opportunities. Frontiers in Aging Neuroscience 10.
Crossref
Crossref
Arun K. Kodoth, Vivek M. Ghate, Shaila A. Lewis & Vishalakshi Badalamoole. (2018) Application of pectin‑zinc oxide hybrid nanocomposite in the delivery of a hydrophilic drug and a study of its isotherm, kinetics and release mechanism. International Journal of Biological Macromolecules 115, pages 418-430.
Crossref
Crossref
Sarabjit Kaur, Priya Manhas, Anuradha Swami, Ranjana Bhandari, Krishna K. Sharma, Rahul Jain, Ravinder Kumar, Satish K. Pandey, Anurag Kuhad, Rohit K. Sharma & Nishima Wangoo. (2018) Bioengineered PLGA-chitosan nanoparticles for brain targeted intranasal delivery of antiepileptic TRH analogues. Chemical Engineering Journal 346, pages 630-639.
Crossref
Crossref
Shadab Md, Subrat K. Bhattmisra, Farrukh Zeeshan, Naiyer Shahzad, Md Ali Mujtaba, Venkata Srikanth Meka, Ammu Radhakrishnan, Prashant Kesharwani, Sanjula Baboota & Javed Ali. (2018) Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 43, pages 295-310.
Crossref
Crossref
N. Poovaiah, Z. Davoudi, H. Peng, B. Schlichtmann, S. Mallapragada, B. Narasimhan & Q. Wang. (2018) Treatment of neurodegenerative disorders through the blood–brain barrier using nanocarriers. Nanoscale 10:36, pages 16962-16983.
Crossref
Crossref
Haisheng He, Sifan Jiang, Yunchang Xie, Yi Lu, Jianping Qi, Xiaochun Dong, Weili Zhao, Zongning Yin & Wei Wu. (2018)
Reassessment of long circulation
via
monitoring of integral polymeric nanoparticles justifies a more accurate understanding
. Nanoscale Horizons 3:4, pages 397-407.
Crossref
Crossref
Moises Job Galindo-Pérez, David Quintanar-Guerrero, María de los Ángeles Cornejo-Villegas & María de la Luz Zambrano-Zaragoza. (2018) Optimization of the emulsification-diffusion method using ultrasound to prepare nanocapsules of different food-core oils. LWT 87, pages 333-341.
Crossref
Crossref
Abdur Rauf Khan, Mengrui Liu, Muhammad Wasim Khan & Guangxi Zhai. (2017) Progress in brain targeting drug delivery system by nasal route. Journal of Controlled Release 268, pages 364-389.
Crossref
Crossref
Ming Ming Wen, Noha S. El-Salamouni, Wessam M. El-Refaie, Heba A. Hazzah, Mai M. Ali, Giovanni Tosi, Ragwa M. Farid, Maria J. Blanco-Prieto, Nashiru Billa & Amira S. Hanafy. (2017) Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges. Journal of Controlled Release 245, pages 95-107.
Crossref
Crossref
Sara Hernando, Enara Herran, Jose Luis Pedraz, Manoli Igartua & Rosa Maria Hernandez. 2017. Drug and Gene Delivery to the Central Nervous System for Neuroprotection. Drug and Gene Delivery to the Central Nervous System for Neuroprotection
57
87
.
Sara Hernando, Oihane Gartziandia, Enara Herran, Jose Luis Pedraz, Manoli Igartua & Rosa Maria Hernandez. (2016) Advances in nanomedicine for the treatment of Alzheimer’s and Parkinson’s diseases. Nanomedicine 11:10, pages 1267-1285.
Crossref
Crossref
Pennapa Chonpathompikunlert, Toru Yoshitomi, Long Binh Vong, Natsuka Imaizumi, Yuki Ozaki & Yukio Nagasaki. (2015) Recovery of Cognitive Dysfunction via Orally Administered Redox-Polymer Nanotherapeutics in SAMP8 Mice. PLOS ONE 10:5, pages e0126013.
Crossref
Crossref
Randall A. Meyer, Joel C. Sunshine, Karlo Perica, Alyssa K. Kosmides, Kent Aje, Jonathan P. Schneck & Jordan J. Green. (2015) Biodegradable Nanoellipsoidal Artificial Antigen Presenting Cells for Antigen Specific T-Cell Activation. Small 11:13, pages 1519-1525.
Crossref
Crossref
Matthias van Woensel, Nathalie Wauthoz, Rémi Rosière, Karim Amighi, Véronique Mathieu, Florence Lefranc, Stefaan van Gool & Steven de Vleeschouwer. (2013) Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?. Cancers 5:4, pages 1020-1048.
Crossref
Crossref
Massimo Masserini. (2013) Nanoparticles for Brain Drug Delivery. ISRN Biochemistry 2013, pages 1-18.
Crossref
Crossref